| P2093 | author name string | Xing Zhang | |
| | Yi-Xin Zeng | |
| | Jiang Li | |
| | Rui-Qing Peng | |
| | Xiao-Shi Zhang | |
| | Ya Ding | |
| | De-Sen Wan | |
| | Xiao-Jun Wu | |
| | Zhi-Zhong Pan | |
| | Yan-Fang Gao | |
| P2860 | cites work | Exosomes as a tumor immune escape mechanism: possible therapeutic implications | Q21245472 |
| | Prevention of allogeneic fetal rejection by tryptophan catabolism | Q24336018 |
| | rIFN-gamma-mediated growth suppression of platinum-sensitive and -resistant ovarian tumor cell lines not dependent upon arginase inhibition | Q24805224 |
| | The changes of CD4+CD25+/CD4+ proportion in spleen of tumor-bearing BALB/c mice | Q24805327 |
| | Progress and controversies in developing cancer vaccines | Q24810256 |
| | Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase | Q28204166 |
| | Biochemical and medical aspects of the indoleamine 2,3-dioxygenase-initiated L-tryptophan metabolism | Q28273442 |
| | Inhibition of indoleamine 2,3-dioxygenase in dendritic cells by stereoisomers of 1-methyl-tryptophan correlates with antitumor responses | Q28283999 |
| | IDO expression by dendritic cells: tolerance and tryptophan catabolism | Q29614752 |
| | Inhibition of indoleamine 2,3-dioxygenase, an immunoregulatory target of the cancer suppression gene Bin1, potentiates cancer chemotherapy. | Q34394487 |
| | Immune escape as a fundamental trait of cancer: focus on IDO. | Q34758085 |
| | Inhibition of experimental asthma by indoleamine 2,3-dioxygenase | Q35835456 |
| | Expression of indoleamine 2,3-dioxygenase by plasmacytoid dendritic cells in tumor-draining lymph nodes. | Q35835489 |
| | Plasmacytoid dendritic cells from mouse tumor-draining lymph nodes directly activate mature Tregs via indoleamine 2,3-dioxygenase | Q35925641 |
| | Indoleamine 2,3-dioxygenase, tumor-induced tolerance and counter-regulation | Q36388171 |
| | Tumor-infiltrating macrophages and dendritic cells in human colorectal cancer: relation to local regulatory T cells, systemic T-cell response against tumor-associated antigens and survival | Q36402098 |
| | Regulatory T cells, tumour immunity and immunotherapy | Q36430144 |
| | Immune resistance orchestrated by the tumor microenvironment | Q36593747 |
| | The tumor-draining lymph node as an immune-privileged site | Q36593753 |
| | Indoleamine 2,3-dioxygenase is a novel prognostic indicator for endometrial cancer | Q36612457 |
| | Molecules in focus: indoleamine 2,3-dioxygenase. | Q36744423 |
| | Tryptophan catabolism in IDO+ plasmacytoid dendritic cells. | Q36789443 |
| | Role of indoleamine 2,3-dioxygenase in antimicrobial defence and immuno-regulation: tryptophan depletion versus production of toxic kynurenines. | Q36789457 |
| | Indoleamine 2,3-dioxygenase and tumor-induced tolerance | Q36809762 |
| | Tumor immune escape mediated by indoleamine 2,3-dioxygenase | Q36888330 |
| | Is IDO a key enzyme bridging the gap between tumor escape and tolerance induction? | Q37026760 |
| | Uveal melanoma expression of indoleamine 2,3-deoxygenase: establishment of an immune privileged environment by tryptophan depletion | Q37224538 |
| | T cell regulatory plasmacytoid dendritic cells expressing indoleamine 2,3 dioxygenase | Q37334065 |
| | Inhibitors of indoleamine-2,3-dioxygenase for cancer therapy: can we see the wood for the trees? | Q37492248 |
| | Foxp3 expression in human cancer cells. | Q38524958 |
| | A novel cancer therapy by skin delivery of indoleamine 2,3-dioxygenase siRNA. | Q39894586 |
| | Critical role of indoleamine 2,3-dioxygenase in tumor resistance to repeated treatments with targeted IFNgamma | Q39906069 |
| | Overexpression of indoleamine 2,3-dioxygenase in human endometrial carcinoma cells induces rapid tumor growth in a mouse xenograft model | Q39916520 |
| | Tumor-induced CD11b+Gr-1+ myeloid cells suppress T cell sensitization in tumor-draining lymph nodes | Q39949096 |
| | Expression of indoleamine 2,3-dioxygenase in metastatic pancreatic ductal adenocarcinoma recruits regulatory T cells to avoid immune detection | Q39983492 |
| | Expression and prognosis role of indoleamine 2,3-dioxygenase in hepatocellular carcinoma | Q39988114 |
| | Expression of indoleamine 2,3-dioxygenase in tumor endothelial cells correlates with long-term survival of patients with renal cell carcinoma | Q40041177 |
| | Indoleamine 2,3-dioxygenase (IDO) expression in lung cancer | Q40093637 |
| | Reinstalling antitumor immunity by inhibiting tumor-derived immunosuppressive molecule IDO through RNA interference | Q40224792 |
| | Prognostic value of indoleamine 2,3-dioxygenase expression in colorectal cancer: effect on tumor-infiltrating T cells. | Q40314157 |
| | Indoleamine 2,3-dioxygenase activity and L-tryptophan transport in human breast cancer cells | Q40589307 |
| | Mechanisms of local immunosuppression in cutaneous melanoma. | Q41808459 |
| | More insights into the immunosuppressive potential of tumor exosomes. | Q43237241 |
| | Indoleamine 2,3-dioxygenase expression in transplanted NOD Islets prolongs graft survival after adoptive transfer of diabetogenic splenocytes. | Q43867525 |
| | Inverse correlation between tumoral indoleamine 2,3-dioxygenase expression and tumor-infiltrating lymphocytes in endometrial cancer: its association with disease progression and survival | Q44776511 |
| | Expression of indoleamine 2,3-dioxygenase in carcinoma of human endometrium and uterine cervix. | Q44943815 |
| | Indoleamine 2,3-dioxygenase as a new target for malignant glioma therapy. Laboratory investigation. | Q46130460 |
| | The immunoregulatory role of IDO-producing human dendritic cells revisited | Q46889954 |
| | Enhancement of dendritic cell-tumor fusion vaccine potency by indoleamine-pyrrole 2,3-dioxygenase inhibitor, 1-MT. | Q46971502 |
| | CD25 and indoleamine 2,3-dioxygenase are up-regulated by prostaglandin E2 and expressed by tumor-associated dendritic cells in vivo: additional mechanisms of T-cell inhibition | Q46979779 |
| | Suppression of islet allogeneic immune response by indoleamine 2,3 dioxygenase-expressing fibroblasts. | Q50685823 |
| | Metastatic tumour cells favour the generation of a tolerogenic milieu in tumour draining lymph node in patients with early cervical cancer. | Q51959038 |
| | Effect of melanoma on immune function in the regional lymph node basin. | Q54548294 |
| | Increased synthesis of indoleamine-2,3-dioxygenase protein is positively associated with impaired survival in patients with serous-type, but not with other types of, ovarian cancer | Q56786153 |
| | THE role of indoleamine 2,3-dioxygenase in the anti-tumour activity of human interferon-γin vivo | Q61819257 |
| | Ep-CAM overexpression in breast cancer as a predictor of survival | Q73328477 |
| P304 | page(s) | 71 | |
| P577 | publication date | 2009-08-20 | |
| P1433 | published in | Journal of Translational Medicine | Q15716664 |
| P1476 | title | The paradoxical patterns of expression of indoleamine 2,3-dioxygenase in colon cancer | |
| P478 | volume | 7 | |